Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement

NCT03724084 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

NIH

Sponsor class

Stopped Other - Study agent no longer available

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Daunorubicin
DRUG: Daunorubicin Hydrochloride
DRUG: Pinometostat

Sponsor

National Cancer Institute (NCI)